Boston, MA · Founded 2018 · Privately Held (backing)
Developer of an AI-powered healthcare technology platform designed to identify novel drugs across a wide spectrum of diseases. Dewpoint Therapeutics is based in Boston, MA and was founded in 2018. Its last reported valuation was $500 million in Feb 2022. It has raised $345 million across 3 recorded rounds; the latest was a $59.1 million later-stage round in Sep 2025.
Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$345.3M
Last round
Later Stage VC
Sep 2025
Cap table — not yet on record
Dewpoint Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dewpoint Therapeutics with a free account
·The complete investor list: 18 names
·Watch Dewpoint Therapeutics: the Monday email on marks, rounds and moves
Where does Dewpoint Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Dewpoint Therapeutics's 3 recorded funding rounds.
